However, it has been reported that CABYR-a/b increases tumour necrosis factor receptor superfamily, member 10b (DR5) expression and sensitizes lung cancer cells to the tumour necrosis factor-related apoptosis-inducing Ligand (TRAIL)-induced apoptosis in vitro and in vivo (54). The gene discussed is CABYR; the disease is lung carcinoma.